New attack on returning melanoma: Double-Drug blitz before surgery
NCT ID NCT06365619
Summary
This study is testing if giving two immunotherapy drugs (ipilimumab and nivolumab) before surgery can help control melanoma that has come back after a patient's initial treatment. About 25 adults with high-risk, operable melanoma that returned during or shortly after their last therapy will receive two cycles of these drugs, then have standard surgery. Researchers will check if the drugs shrink the tumor before surgery and monitor side effects and long-term outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huntsman Cancer Institute
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.